PANJON LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.38 INR | +0.73% |
|
+3.19% | +10.24% |
| 27/05 | Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 27/05 | Panjon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 8.43Cr 10.11L | Sales 2023 | 6.09Cr 7L | Capitalization | 18Cr 21.68L |
|---|---|---|---|---|---|
| Net income 2022 | -4.1Cr -5L | Net income 2023 | 80L 95.89T | EV / Sales 2022 | 3.16 x |
| Net cash position 2022 | 62.56L 74.99T | Net cash position 2023 | 69.02L 82.72T | EV / Sales 2023 | 2.86 x |
| P/E ratio 2022 |
-6.57
x | P/E ratio 2023 |
22.3
x | Employees | 5 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.49% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.73% | ||
| 1 week | +3.19% | ||
| Current month | +1.41% | ||
| 1 month | +5.67% | ||
| 3 months | -3.05% | ||
| 6 months | +10.87% | ||
| Current year | +10.24% |
1 week
18.02
20.30
1 month
16.6020.99
Current year
16.0021.79
1 year
11.9021.79
3 years
11.3035.95
5 years
11.3035.95
10 years
11.3035.95
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 03/15/03 | |
| Director of Finance/CFO | - | 03/15/03 | |
| Compliance Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 03/15/03 | |
Anju Kothari
BRD | Director/Board Member | - | 14/19/14 |
| Director/Board Member | 43 | 27/17/27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 19.38 | +0.73% | 14 367 |
| 01/24/01 | 19.24 | +0.68% | 14,445 |
| 28/24/28 | 19.11 | -0.83% | 6,716 |
| 27/24/27 | 19.27 | +2.83% | 8,045 |
| 26/24/26 | 18.74 | -0.21% | 4,349 |
Delayed Quote Bombay S.E., July 02, 2024 at 03:30 pm IST
More quotes
Panjon Limited is an India-based company that is engaged in the manufacturing and trading of consumer and pharmaceutical products. The Company is primarily engaged in manufacturing and trading of allopathic and ayurvedic medicines. The Company specializes in medicinal, digestive, ayurvedic and confectionary products. The Company's brands include Panjon and Swad. The Company's products include PANJON Tablet, PANJON Balm, PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Digestive Drops, Percy Masala Candy, KERY Cough Drops, PANJON Dental Care Cream and others. The Company's subsidiary company is Raunaq Laboratories Ltd.
Sector
Pharmaceuticals
Calendar
06/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +10.24% | 37.6L | |
| +56.86% | 82TCr | |
| +40.02% | 64TCr | |
| -6.57% | 35TCr | |
| +17.32% | 32TCr | |
| +9.94% | 30TCr | |
| +15.11% | 24TCr | |
| +1.55% | 22TCr | |
| +13.22% | 22TCr | |
| +7.98% | 17TCr |
- Stock Market
- Equities
- PANJON Stock
